Skip to main content
. 2020 Jun 27;12(7):694. doi: 10.3390/v12070694

Table 1.

Characteristics of Virology Quality Assurance (VQA) specimens used in this study.

Specimen Viral Load a Subtype b PR DRMs c RT DRMs c % Mixed Bases in SS Consensus d Number of Amplification Failures
24.1 7815 B None T215C 2.3% 0
24.2 18,023 F K20R, M36I None 0.0% 0
24.3 26,372 C M36I M41L, V75T, V90I, V106M, V179D 0.0% 0
24.4 29,139 C M36I M41L, K103N, M184V, T215Y 0.1% 1
24.5 6424 B L10I, L33F, M46L, I54V, A71I/T, V82A, L90M M41L, E44D, A62V, D67N, L74V, L100I, K103N, H208Y, L210W, T215Y H221Y 0.8% 1
26.1 16,685 C M36I, T74S D67N, K70R, V90I, M184V 0.9% 0
26.2 e 4513 B L10I, L33F, M46L, I54V, A71I/T, V82A, L90M M41L, E44D, A62V, D67N, L74V, L100I, K103N, H208Y, L210W, T215Y, H221Y 1.1% 1
26.3 18,213 C K20R, M36I A62V, K65R, D67N, V75A/I/T, K101Q, K103N, V106M, E138A, M184V 2.1% 1
26.4 6506 D M36I None 1.1% 2
26.5 3656 B none V90I, K103N 3.8% 0

a RNA copies/mL. b determined based on protease (PR)- reverse transcriptase (RT) sequence and Stanford HIVdb. c Drug resistance-associated mutation (DRM) sites were defined as any position with a potential impact on the penalty score in the Stanford HIVdb algorithm (version 8.5). d percentage of nucleotides in the VQA Sanger consensus sequence that are mixed, including positions where consensus was not reached. e same donor virus as 24.5.